Atlas Venture Fund X, L.P. Insider Trading

Get the latest insider transactions of Atlas Venture Fund X, L.P.. Atlas Venture Fund X, L.P. is 10% Owner in AVROBIO, Inc. ($AVRO) and 10% Owner in Magenta Therapeutics, Inc. ($MGTA) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Replimune Group, Inc. ($REPL) and 10% Owner in Kymera Therapeutics, Inc. ($KYMR) and 10% Owner in Ikena Oncology, Inc. ($IKNA). Discover the current value of Atlas Venture Fund X, L.P. shares.

Address: 400 TECHNOLOGY SQ., 10TH FLOOR CAMBRIDGE 02139MA

Atlas Venture Fund X, L.P. is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
AVROAVROBIO, Inc.10% Owner5,567,289
MGTAMagenta Therapeutics, Inc.10% Owner4,117,125
REPLReplimune Group, Inc.10% Owner2,486,296
GBIOGeneration Bio Co.10% Owner8,111,939
KYMRKymera Therapeutics, Inc.10% Owner6,885,631
IKNAIkena Oncology, Inc.10% Owner2,901,609

Insider Trading Transactions of Atlas Venture Fund X, L.P.

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jun 21 2021GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.001,000,00008,111,939
Jun 21 2021GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.001,000,00008,111,939
Jun 21 2021GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.00100,00001,266,937
Jun 21 2021GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.00100,00001,266,937
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.002,901,60902,901,609
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.001,099,11801,268,213
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.00749,6340749,634
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.009,499,99900
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.0011,258,11700
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.007,863,09400
Apr 01 2021IKNAIkena Oncology, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.005,362,88800
Mar 18 2021GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.001,000,00009,111,939
Feb 22 2021KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerSell0.001,063,35106,885,631
Dec 17 2020GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerSell0.001,151,882011,478,876
Sep 17 2020REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerSell0.00445,33902,486,296
Sep 17 2020REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerSell0.00445,33902,486,296
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.007,196,58407,948,982
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.001,112,68601,112,686
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.003,000,00000
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.007,000,00000
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.001,477,83200
Aug 25 2020KYMRKymera Therapeutics, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.001,774,62400
Jul 07 2020REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerSell0.00445,33902,931,635
Jun 18 2020REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerSell0.00445,33903,376,974
Jun 18 2020GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerBuy0.0010,040,032012,630,758
Jun 18 2020GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.0015,051,02000
Jun 18 2020GBIOGeneration Bio Co.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.00268,26900
Jul 23 2019AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy18.50810,81115,000,0045,567,289
Mar 22 2019MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerSell0.00726,50004,117,125
Mar 22 2019MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerBuy0.0014,245014,245
Mar 22 2019MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerSell17.8614,245254,4160
Jul 26 2018REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.003,439,83903,439,839
Jul 26 2018REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.001,013,54704,453,386
Jul 26 2018REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.003,439,83900
Jul 26 2018REPLReplimune Group, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.001,013,54700
Jun 27 2018MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerBuy0.004,746,87604,843,625
Jun 27 2018MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.0012,061,49600
Jun 27 2018MGTAMagenta Therapeutics, Inc ...Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.00204,33900
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.00806,7110806,711
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.003,044,57903,851,290
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerBuy0.00905,18804,756,478
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.003,333,33300
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.0012,580,19900
Jun 25 2018AVROAVROBIO, Inc.Atlas Venture Fund X, L.P.10% OwnerOption Exercise0.003,740,23900